Literature DB >> 4777259

Fate of the analgesic and anti-inflammatory drug K 4277 after oral administration to man.

L M Fuccella, G C Goldaniga, E Moro, V Tamassia, G P Tosolini, G Valzelli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4777259     DOI: 10.1007/bf00644742

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  4 in total

1.  New analgesic-anti-inflammatory drugs. 1-Oxo-2-substituted isoindoline derivatives.

Authors:  G Nannini; P N Giraldi; G Molgora; G Biasoli; F Spinelli; W Logemann; E Dradi; G Zanni; A Buttinoni; R Tommasini
Journal:  Arzneimittelforschung       Date:  1973-08

2.  Pharmacological study on a new analgesic-anti-inflammatory drug: alpha-(4-(1-oxo-2-iso-indolinyl)-phenyl)-propionic acid of K 4277.

Authors:  A Buttinoni; A Cuttica; J Franceschini; V Mandelli; G Orsini; N Passerini; C Turba; R Tommasini
Journal:  Arzneimittelforschung       Date:  1973-08

3.  Concept of a volume of distribution and possible errors in evaluation of this parameter.

Authors:  S Riegelman; J Loo; M Rowland
Journal:  J Pharm Sci       Date:  1968-01       Impact factor: 3.534

4.  Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.

Authors:  S Riegelman; J C Loo; M Rowland
Journal:  J Pharm Sci       Date:  1968-01       Impact factor: 3.534

  4 in total
  3 in total

1.  Indoprofen and naproxen in the treatment of rheumatoid arthritis: a clinical trial.

Authors:  H Berry; L Fernandes; A K Clarke; E B Hamilton; J Davies; A J Dixon
Journal:  Br Med J       Date:  1978-02-04

2.  Effect of analgesic agents on emptying of the gallbladder in man.

Authors:  G Sacchetti; L Roncoroni; V Mandelli; F Rocca; E Magni
Journal:  Eur J Clin Pharmacol       Date:  1976-06-15       Impact factor: 2.953

3.  Stereoselective disposition of indoprofen in surgical patients.

Authors:  S Björkman
Journal:  Br J Clin Pharmacol       Date:  1985-11       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.